HepaHope Inc is a company based in the United States engaged in the medical research, as well as patenting and commercialization of medical technologies. It focuses on three activities: liver replacement, oncology testing and drug development. Its product portfolio includes HepaPheresis System, an extracorporeal toxin management system that assists a patient’s liver by removing toxins from the bloodstream; Chemosensitivity Testing System, enabling oncologists to apply different anti-cancer drugs and drug combinations to multiple tissue samples and thereby to determine the most effective drug or drug combination to destroy a cancer tumor, and BioTester, a drug screening testing system developed for the pharmaceutical industry to provide an alternative to in vivo or in vitro studies.
Quick Financial Synopsis
BRIEF: . . . . . . . .
Company Address
HepaHope, Inc.
30 Fairbanks, Suite 110 Irvine 92618
P: +1949.4213600 F: +1949.4213680